Collegium Pharmaceutical, Inc
COLL· Nasdaq
COLLCollegium Pharmaceutical, Inc
Filed Nov 12, 2015 · 10-Q · 43 days after period end · 0001558370-15-002623
| Metric | Q3 2015 | Q3 2014 |
|---|---|---|
| Net Income | -$9.36M | -$6.56M |
| EPS Diluted | -$0.46 | -$7.85 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Collegium Pharmaceutical, Inc · CIK 1267565 · Engraved from SEC EDGAR
ended Sep 30, 2015 · filed Nov 12, 2015 · 43 d after period end
